The COVID-19 pandemic has caused economic disruption in many major segments of North America, Europe, and APAC regions. For healthcare M&A this has translated into the collapse of deals that were underway and limited options for companies in the healthcare M&A space. How can healthcare M&A recover from the business implications of the COVID-19 pandemic? Infiniti’s experts observed that the high dependency on healthcare is expected to cause a surge in valuations once the situation normalizes. With Infiniti’s M&A support solutions, healthcare companies can focus on finding the ideal deal shortly and gain data-driven guidance from our experts. To stay a step ahead of changing market dynamics, and tackle the impact of the COVID-19 crisis on healthcare M&A, request a free proposal.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201001005753/en/
Three Major Challenges Impacting the Healthcare M&A Space During the COVID-19 Crisis (Graphic: Business Wire)
The global healthcare sector has witnessed challenging times due to the COVID-19 pandemic in recent times. Healthcare institutions, medical professionals, and healthcare company boards are attempting to cope with the pandemic’s startling changes. The healthcare M&A space was similarly impacted, and healthcare mergers have reduced substantially in the second quarter of 2020. As the world works towards recovery, healthcare companies need to understand the impact of the COVID-19 crisis on healthcare M&A and accordingly prepare for the future. Therefore, in their recent article, Infiniti’s M&A support experts discuss the biggest challenges of COVID-19 in the healthcare space, and two minor factors positively impacting the recovering healthcare M&A space.
“While investor support has increased due to the increasing need for healthcare globally, social and political unrest, struggling economies and volatility in financial markets are testing the healthcare industry. Healthcare M&A may be one of the most effective solutions to this crisis,” says an M&A support expert at Infiniti Research.
Speak to our industry experts to gain data-driven insights on the implications of COVID-19 in the healthcare industry, and strategize for the post-COVID era.
Infiniti’s experts identified the following three major challenges caused by the COVID-19 pandemic in healthcare M&A:
Nationwide lockdowns and limitations for governing bodies have led to delays in acquiring regulatory clearance.
The impact of COVID-19 on healthcare M&A participants will change the valuation of both the buyer and seller.
Due to renewed safety and hygiene protocols, and social distancing has made it challenging for companies to conduct thorough due diligence, and delayed third-party approvals.
Gain comprehensive insights into the impact and solutions of these major challenges by reading the complete article here.
About Infiniti Research
Established in 2003, Infiniti Research is a leading market intelligence company providing smart solutions to address your business challenges. Infiniti Research studies markets in more than 100 countries to analyze competitive activity, see beyond market disruptions and develop intelligent business strategies. To know more, visit: https://www.infinitiresearch.com/about-us
View source version on businesswire.com: https://www.businesswire.com/news/home/20201001005753/en/
US: +1 844 778 0600
UK: +44 203 893 3400